Literature DB >> 22963649

Reciprocal influence of alliance to the group and outcome in day treatment for eating disorders.

Giorgio A Tasca1, Amy M Lampard.   

Abstract

The nature of the alliance-outcome relationship is still emerging. This study examined the reciprocal influence of change in alliance to the group and change in urge to restrict in eating-disordered individuals attending a group-based day treatment. Participants (N = 238) were a transdiagnostic or mixed diagnostic sample of eating-disordered individuals consecutively admitted to a day treatment program. On a weekly basis, participants completed a measure of alliance to the group of patients with whom they attended multiple group therapies each week. After each meal, they rated the intensity of their urge to restrict food intake, and the intensity ratings were averaged per week. Latent change score analysis was used to assess the reciprocal relationship between prior change in alliance to the group with subsequent change in urge to restrict, and prior change in urge to restrict with subsequent change in alliance to the group across each participant's first 9 weeks in the program. A reciprocal causal model was a good fit to the data. Prior growth in alliance to the group was significantly associated with subsequent reduction in urge to restrict, and concurrently, prior reduction in urge to restrict was significantly associated with subsequent growth in alliance to the group. Alliance to the group and individual outcomes are dynamically related and changing constructs represented by a reciprocal causal model. Clinicians may improve group treatment by assessing alliance to the group and outcomes repeatedly, being aware of their interplay, and structuring interventions based on the mutual causal effects of change in each. (c) 2012 APA, all rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22963649     DOI: 10.1037/a0029947

Source DB:  PubMed          Journal:  J Couns Psychol        ISSN: 0022-0167


  7 in total

1.  A re-examination of process-outcome relations in cognitive therapy for depression: Disaggregating within-patient and between-patient effects.

Authors:  Katherine E Sasso; Daniel R Strunk; Justin D Braun; Robert J DeRubeis; Melissa A Brotman
Journal:  Psychother Res       Date:  2015-04-16

2.  Working alliance predicts symptomatic improvement in public hospital-delivered psychotherapy in Nairobi, Kenya.

Authors:  Fredrik Falkenström; Mary Kuria; Caleb Othieno; Manasi Kumar
Journal:  J Consult Clin Psychol       Date:  2018-11-15

Review 3.  Developing more efficient, effective, and disseminable treatments for eating disorders: an overview of the multiphase optimization strategy.

Authors:  Stephanie M Manasse; Kelsey E Clark; Adrienne S Juarascio; Evan M Forman
Journal:  Eat Weight Disord       Date:  2019-01-02       Impact factor: 4.652

4.  Does alliance predict symptoms throughout treatment, or is it the other way around?

Authors:  Sigal Zilcha-Mano; Ulrike Dinger; Kevin S McCarthy; Jacques P Barber
Journal:  J Consult Clin Psychol       Date:  2013-11-25

5.  Successful application of adaptive emotion regulation skills predicts the subsequent reduction of depressive symptom severity but neither the reduction of anxiety nor the reduction of general distress during the treatment of major depressive disorder.

Authors:  Carolin M Wirtz; Anna Radkovsky; David D Ebert; Matthias Berking
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  Predictors of therapeutic alliance in two treatments for adults with severe and enduring anorexia nervosa.

Authors:  Colleen Stiles-Shields; Bryony H Bamford; Stephen Touyz; Daniel Le Grange; Phillipa Hay; Hubert Lacey
Journal:  J Eat Disord       Date:  2016-04-05

7.  Alliance across group treatment for veterans with posttraumatic stress disorder: The role of interpersonal trauma and treatment type.

Authors:  Johanna Thompson-Hollands; Scott D Litwack; Karen A Ryabchenko; Barbara L Niles; J Gayle Beck; William Unger; Denise M Sloan
Journal:  Group Dyn       Date:  2018-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.